Professional Summary
Professional Overview
Zili Li is a seasoned pharmaceutical executive with over 20 years of experience in global regulatory affairs, research and development, and strategic industry leadership. As the Vice President and Head of Asia Pacific R&D at The Janssen Pharmaceutical Companies of Johnson & Johnson, he oversees the company's research and development initiatives across the Asia Pacific region, driving innovation and advancing Janssen's pipeline of innovative therapies.
Experience Summary
Current Role
In his role as Vice President and Head of Asia Pacific R&D at Janssen, Zili Li is responsible for leading the company's research and development efforts in the Asia Pacific region. He works closely with cross-functional teams to identify and pursue emerging market opportunities, ensure compliance with local regulatory requirements, and spearhead the development and commercialization of Janssen's portfolio of pharmaceutical products. Under his leadership, the Asia Pacific R&D team has achieved significant milestones, including the successful launch of several new therapies and the expansion of Janssen's research footprint in key markets.
Career Progression
Prior to his current position, Zili Li held various senior-level roles in the pharmaceutical industry and regulatory agencies. He served as the Associate Director and Head of Global Affairs at the FDA's Office of Generic Drugs, where he played a pivotal role in shaping regulatory policies and strategies to support the development and approval of generic medications. Additionally, he has held leadership positions at the Bill & Melinda Gates Foundation, Merck, and the FDA, where he leveraged his expertise in regulatory affairs, research and development, and emerging market strategy to drive innovation and improve patient access to essential medicines.
Academic Background
Zili Li holds a Doctor of Medicine (MD) degree from Peking Union Medical College, as well as two Master of Public Health (MPH) degrees, one in Healthcare Management from the Johns Hopkins Bloomberg School of Public Health and another in Epidemiology from San Diego State University. His diverse educational background and extensive training in public health, regulatory affairs, and clinical research have equipped him with a comprehensive understanding of the pharmaceutical industry and the complex regulatory landscape.
Areas of Expertise
- Pharmaceutical research and development
- Regulatory affairs and policy development
- Emerging market strategy and market access
- Global healthcare program management
- Cross-functional team leadership and collaboration
- Strategic decision-making and problem-solving
Professional Impact
Throughout his career, Zili Li has made significant contributions to the pharmaceutical industry and the broader healthcare landscape. He has been instrumental in the successful development and approval of numerous pharmaceutical products, both in the United States and across global markets. Additionally, his leadership in regulatory affairs has helped shape policies and guidelines that have improved patient access to essential medicines, particularly in emerging markets. Zili's deep industry expertise, combined with his strategic vision and collaborative approach, have positioned him as a respected and influential leader in the Asia Pacific pharmaceutical sector.
Conclusion
With his extensive experience, strong technical competencies, and proven track record of driving innovation and success, Zili Li is poised to continue making a significant impact in the pharmaceutical industry. As the Vice President and Head of Asia Pacific R&D at Janssen, he is well-equipped to lead the company's research and development efforts in the region, contributing to the development of groundbreaking therapies and enhancing patient outcomes.
